Nia Therapeutics, Inc.NT
SEC Form D filing

Nia Therapeutics, Inc.

Biotech · Series B · Regulation D 506(b) · MA · Filed June 3, 2026

Offering amount
$26.5M
Exemption
Reg D 506(b)
Issuer state
MA
Filing date
June 3, 2026
Signature date
June 3, 2026
CIK
0001758725

Summary

Auto-generated

Biotech therapeutics company, $26.5M series-b, MA-based.

Generated automatically by a language model from the public SEC filing; may contain errors. Verify against the source document on EDGAR. FormDFlow surfaces public-disclosure data from SEC EDGAR. Nothing here is investment advice.

Source

View on SEC EDGAR →Get alerts for filings like this →

FormDFlow surfaces public-disclosure data from SEC EDGAR. Nothing here is investment advice.